Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 2, 2010, Pages 113-118

  Stenzel, Stephanie L ^a   Krull, Kevin R ^b   Hockenberry, Marilyn ^c   Jain, Neelam ^b   Kaemingk, Kris ^e   Miketova, Petra ^d   Moore, Ida M ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e NONE

Author keywords

Neurobehavioral outcomes; Oxidative stress; Pediatric leukemia

Indexed keywords

METHOTREXATE; PHOSPHATIDYLCHOLINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGGRESSION; ARTICLE; BEHAVIOR DISORDER; CANCER CHEMOTHERAPY; CEREBROSPINAL FLUID ANALYSIS; CHILD; COGNITION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ANTINEOPLASTIC AGENTS; BRAIN; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; METHOTREXATE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 77949459815     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181c9af84     Document Type: Article

References (34)

1. Ries LAG, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub No 99-4649 1999.
2. Gatta G, Capocaccia R, Coleman MP, et al. Childhood cancer survival in Europe and the United States. Cancer. 2002;95: 1767-1772.
3. Brouwers P. Commentary: study of the neurobehavioral consequences of childhood cancer: entering the genomic era? J Pediatr Psychol. 2005;30:79-84.
4. Espy KA, Moore IM, Kaufmann PM, et al. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol. 2001;26:1-9.
5. Raymond-Speden E, Tripp G, Lawrence B, et al. Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. J Pediatr Psychol. 2000;25:59-68.
6. Montour-Proulx I, Kuehn SM, Keene DL, et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol. 2005;20:129-133.
7. Brown RT, Madan-Swain A, Pais R, et al. Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae. J Pediatr. 1992;121:885-889.
8. Buizer AI, de Sonneville LMJ, van den Heuvel-Eibrink MM, et al. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer. 2005;45:281-290.
9. Buizer AI, de Sonneville LMJ, van den Heuvel-Eibrink MM, et al. Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. Cancer. 2006;106:2067-2075.
10. Pä äkköE, Harila-Saari A, Vanionpä ä L, et al. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol. 2000;35:456-461.
11. Leung W, Hudson M, Zhu Y, et al. Late effects in survivors of infant leukemia. Leukemia. 2000;14:1185-1190.
12. von der Weid N, Mosimann I, Hirt A, et al. Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sexrelated differences. Eur J Cancer. 2003;39:359-365.
13. Trautman PD, Erickson C, Shaffer D, et al. Prediction of intellectual deficits in children with acute lymphoblastic leukemia. J Develop Behav Pediatr. 1988;9:122-128.
14. Nathan PC, Patel SK, Dilley K, et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med. 2007;161:798-806.
15. Spiegler BJ, Kennedy K, Maze R, et al. Comparison of longterm neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or highdose or very high-dose intravenous methotrexate. J Clin Oncol. 2006;24:3858-3864.
16. Butler RW, Hill JM, Steinherz PG, et al. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol. 1994;12: 2621-2629.
17. Illingworth DR, Glover J. The composition of lipids in cerebrospinal fluid of children and adults. J Neurochem. 1971;18: 769-776.
18. Moore IM, Espy KA, Kaufmann P, et al. Cognitive consequences and central nervous system injury following treatment for childhood leukemia. Semin Oncol Nursing. 2000;16: 279-290; discussion 291.
19. Miketova P, Kaemingk K, Hockenberry M, et al. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia. Biol Res Nursing. 2005;6:187-195.
20. Babiak RM, Campello AP, Carnieri EG, et al. Methotrexate: pentose cycle and oxidative stress. Cell Biochem Function. 1998; 16:283-293.
21. Jahovic N, Cevik H, Sehirli AO, et al. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res. 2003;34:282-287.
22. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998;39:1529-1542.
23. Farooqui AA, Horrocks LA. Lipid peroxides in the free radical pathophysiology of brain diseases. Cell Mol Neurobiol. 1998; 18:599-608.
24. Mawatari S, Murakami K. Analysis of membrane phospholipid peroxidation by isocratic high-performance liquid chromatography with ultraviolet detection. Analytic Biochem. 1998;264:118-123.
25. Reynolds CR, Kamphaus RW. Behavior Assessment System for Children: Manual. Circle Pines, MN: American Guidance Service, Inc; 1992.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
27. Moore BD. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol. 2005;30:51-63.
28. Gillotte KL, HörkköS, Witztum JL, et al. Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors. J Lipid Res. 2000;41: 824-833.
29. Nonas S, Miller I, Kawkitinarong K, et al. Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury. Am J Resp Crit Care Med. 2006;173: 1130-1138.
30. Qin J, Goswami R, Balabanov R, et al. Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J Neurosci Res. 2007;85:977-984.
31. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin. 2004;54:208-236.
32. Colletti CJM, Wolfe-Christensen C, Carpentier MY, et al. The relationship of parental overprotection, perceived vulnerability, and parenting stress to behavioral, emotional, and social adjustment in children with cancer. Pediatr Blood Cancer. 2008;51:269-274.
33. Carey ME, Hockenberry MJ, Moore IM, et al. Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol. 2007;32: 189-193.
34. Mazza M, Pomponi M, Janiri L, et al. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31: 12-26.